22 November 2024

Howe Street Reporter Title

Tag: Diagnos Inc.

  • To Invest or Not: Diagnos (ADK.V)

    To Invest or Not: Diagnos (ADK.V)

    In this episode, we talk about DIAGNOS (ADK.V), a publicly traded Canadian corporation with a mission to commercialize technologies combining contextual imaging, and traditional data mining thereby improving decision making processes. DIAGNOS offers products, services, and solutions to clients in a variety of fields including natural resources, healthcare, and entertainment. We discuss what they do,…

  • Chris’ Corner: Diagnos Inc (ADK.V)

    Chris’ Corner: Diagnos Inc (ADK.V)

    Chris Parry speaks with Andre Larente, president and CEO of DIAGNOS (ADK.V) to get an in-depth look at how their diabetic retinopathy screening services work and what it means for optometrists and patients. Tune in!

  • Diagnos (ADK.V) Renews Contract with Optina Diagnostics

    Diagnos (ADK.V) Renews Contract with Optina Diagnostics

    Diagnos (ADK.V) today announced a contract renewal to provide its telemedicine platform based on CARA (Computer Assisted Retina Analysis) to Optina Diagnostics for an additional three-year period. “This contract renewal is a testimony of the high quality of our telemedicine platform and the agility of DIAGNOS people to adapt its platform to enable the rich…

  • Diagnos (ADK.V) Announces Pilot with Opticalia in Spain

    Diagnos (ADK.V) Announces Pilot with Opticalia in Spain

    Diagnos (ADK.V), a leader in early detection announced today that it has signed a pilot in Spain with three franchisees from Opticalia Group. “The campaign begins with the request for a previous appointment through the web or at the optician itself, where patients will register in order of arrival and a free retinography will be…